Srinivas is a Co-Founder of atai and served as Chief Scientific Officer for five years before becoming Co-Chief Executive in 2023. He refers to himself as being an engineer at heart and credits this mindset for his passion in seeking to understand the brain, particularly as it regards mental health conditions.

With more than two decades of experience in the pharmaceutical industry, he has held the titles of Chief Scientific, Medical and Executive at multiple companies ranging from venture-backed startups to vertically integrated, publicly traded pharmaceutical companies.

Srini completed his internship in Internal Medicine at Yale-New Haven Hospital. He received his medical degree from Yale School of Medicine and holds a Ph.D. in Neurobiology and a Master of Science in Electrical Engineering from Yale Graduate School.